Will APHRIA INC ORDINARY SHARES CANADA (OTCMKTS:APHQF) Run Out of Steam Soon? Short Interest is Up

June 18, 2018 - By Hazel Jackson

The stock of APHRIA INC ORDINARY SHARES CANADA (OTCMKTS:APHQF) registered an increase of 4.92% in short interest. APHQF’s total short interest was 5.38 million shares in June as published by FINRA. Its up 4.92% from 5.13M shares, reported previously. With 1.16M shares average volume, it will take short sellers 5 days to cover their APHQF’s short positions.

The stock decreased 1.24% or $0.11 during the last trading session, reaching $8.77. About 99,049 shares traded. Aphria Inc. (OTCMKTS:APHQF) has 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

Aphria Inc. produces, supplies, and sells medical cannabis in Canada. The company has market cap of $1.86 billion. The firm offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It has a 56.22 P/E ratio. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.

More notable recent Aphria Inc. (OTCMKTS:APHQF) news were published by: Midasletter.com which released: “Canopy Growth Corp, Aphria Inc, MedReleaf Corp’s Takeout by Aurora Cannabis Drives Cannabis Index Higher” on June 04, 2018, also Profitconfidential.com with their article: “Marijuana News Today: Major Vote Upcoming in Canadian Marijuana Legalization” published on June 05, 2018, Midasletter.com published: “Aphria Inc CEO Vic Neufeld Warns Licensed Producer Squeeze Is Coming” on May 29, 2018. More interesting news about Aphria Inc. (OTCMKTS:APHQF) were released by: Profitconfidential.com and their article: “Looking at This Indicator to Confirm the Next Advance in Aphria Stock” published on May 30, 2018 as well as Midasletter.com‘s news article titled: “BMO Initiates Conservative Price Targets on Canopy Growth Corp, Aphria Inc” with publication date: May 30, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: